Back

Effect of combined antiplatelet and anticoagulant therapy in comparison to anticoagulants in monotherapy on CABG outcomes in patients requiring anticoagulants. Analysis of real-world data.

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Updates on single and combined antithrombotic therapy Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Agnieszka Segiet-Swiecicka

National Institute of Cardiology, Warsaw (Poland)

5 More presentations in this session

Presentation thumbnail
BRIDGE: a barrier‑informed Bayesian risk prediction model for risk identification, trajectory grouping, and profiling of non‑adherence to cardioprotective medicines in primary care
Doctor H. Koh (Melbourne, AU) Assistant Professor S. Talic (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Bleeding and mortality risks after intravenous alteplase in stroke patients with prior dual antiplatelet therapy: a nationwide cohort study
Doctor H. Huang (Hualien, TW)
Abstract Slides Video
Presentation thumbnail
Single vs. dual antithrombotic therapy in patients with stabilized coronary artery disease requiring long-term oral anticoagulation: A Bayesian meta-analysis
Doctor P. Sabouret (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.
Doctor C. Gibson (Boston, US) Assistant Professor M. Chiarito (Rozzano, IT)
Abstract Slides Video
Presentation thumbnail
Genotype-guided antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials.
Doctor A. Buffon (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Updates on single and combined antithrombotic therapy

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Dual versus single antiplatelet therapy after coronary artery bypass grafting: a meta-analysis of randomized controlled trials
28 August 2026
thumbnail
Congress Session
What you need to know about antithrombotic therapy in patients after TAVI
28 August 2022
thumbnail
Congress Presentation
Anticoagulant monotherapy versus anticoagulant therapy in combination with single antiplatelet agent in patients after coronary artery bypass grafting - analysis of real-world data
2 September 2024
thumbnail
Congress Presentation
Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources